US2012149717A1PendingUtilityA1
Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
Est. expiryAug 2, 2024(expired)· nominal 20-yr term from priority
A61P 25/04C07D 295/155A61P 25/16A61P 25/22A61P 25/24A61K 31/495
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A compound 4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)piperazin-1-yl]methyl}-N,N-diethylbenzamide, having the formula
or a pharmaceutically acceptable salt thereof.
18 . A pharmaceutical composition comprising a compound according to claim 17 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
19 . A method of treating anxiety, comprising the step of administering to a subject in need of such treatment a therapeutically effective amount of a compound according to claim 17 , or a pharmaceutically acceptable salt thereof.
20 . A method of treating anxiety according to claim 19 , wherein said anxiety is generalized anxiety disorder.
21 . A method of treating anxiety, comprising administering to a subject in need of such treatment a therapeutically effective amount of a composition according to claim 18 .
22 . A method of treating anxiety according to claim 21 , wherein said anxiety is generalized anxiety disorder.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.